Acasti Pharma reported $459K in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Acasti Pharma USD 459K 881K Sep/2025
Addus HomeCare USD 20.13M 2.09M Sep/2026
Amarin USD 40.43M 21.63M Sep/2026
Cassava Sciences USD 39.29M 102K Jun/2026
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Option Care Health USD 670.68M 30.91M Sep/2026
Organigram Holdings CAD 99.93M 26.79M Jun/2026
Tilray USD 114.5M 3.69M Sep/2025